Treatment for
endometrial cancer depends on the size, stage, and
grade of the cancer.
- The stage determines the extent of cancer growth in and
beyond the uterus. Staging is done when the uterus is removed (hysterectomy). The surgeon will examine the other
pelvic organs to look for signs of cancer and remove them if necessary.
- The
grade of endometrial cancer refers to how the cancer cells look under a
microscope. Learning the grade can help your doctor decide which treatments will work best for you.
Endometrial cancer has been classified by the American Joint
Committee on Cancer (AJCC) and the Fédération Internationale de Gynécologie et
d’Obstétrique (FIGO, also called the International Federation of Gynecology and
Obstetrics). The two classification systems are very similar.1
AJCC TNM and FIGO staging classification
The primary tumor (T) is staged in the following way with the AJCC
classification first and the FIGO stage in parentheses:
- TX. Primary tumor cannot
be assessed.
- T0. No primary tumor is
seen.
- Tis (Carcinoma in situ). The cancer is
found only in one area of the
uterus and only in a few layers of
cells.
- T1 (Stage I). Tumor is contained in
the uterus. It has not spread to the
cervix.
- T1a (Stage IA). Tumor is in the lining of the uterus (endometrium) or has spread into less than one-half of the muscle tissue (myometrium)
of the uterus.
- T1b (Stage IB). Tumor has
spread to one-half or more of the myometrium.
- T2 (Stage II). Tumor has spread from the uterus to the cervix but has not spread
outside the uterus.
- T3a (Stage IIIA). Tumor is
on the outer surface of the uterus, or in the
ovaries or
fallopian tubes.
- T3b (Stage IIIB). Tumor has spread
(metastasized) into the tissue layers of the
vagina.
- T4 (Stage IVA). Tumor has spread into the bladder or rectum.
After the tumor (T) is staged, the TNM system stages
lymph node involvement (N) to help determine the
treatment options at each stage. Lymph node involvement is staged in the
following way:
- NX. Lymph nodes near the
primary tumor cannot be evaluated.
- N0.
Cancer has not spread to lymph nodes near the primary tumor.
- N1 (IIIC1). Cancer has spread to lymph nodes near the primary
tumor.
- N2 (IIIC2). Cancer has spread to the lymph nodes near the aorta, with or without spreading to the pelvic lymph nodes.
The last part of staging endometrial cancer is to find out whether
cancer has spread to other areas of the body (metastasized). The TNM system
stages metastasis (M) in the following way:
- M0. No distant
metastasis is found.
- M1 (IVB). Metastasis to
another area of the body has occurred, but not to the vagina, to the pelvic membranes and adjoining tissue, or to the lymph nodes near the aorta.
The TNM staging system allows your doctor to recommend
the most effective treatment options and discuss the long-term outcome
(prognosis) based on the type of tumor, the stage of your cancer, your age and
overall health condition.
The FIGO stages and the AJCC TNM class are grouped in the following
table.
Classification of endometrial cancer|
FIGO stage |
TNM class |
|---|
Stage 0 Stage I Stage IA Stage IB | Tis, N0, M0 T1, N0, M0 T1a, N0, M0 T1b, N0, M0 |
Stage II | T2, N0, M0 |
Stage III Stage IIIA Stage IIIB Stage IIIC1 Stage IIIC2 | T3, N0, M0 T3a, N0, M0 T3b, N0, M0 T1-T3, N1, M0 T1-T3, N2, M0 |
Stage IVA Stage IVB | T4, any N, M0 Any T, any N, M1 |
Grade of endometrial cancer
The grade of endometrial cancer refers to how the cancer cells
look under a microscope. Knowing the grade can help your doctor decide which treatment options are best for you. Endometrial cancer cells are described as
well-differentiated, moderately differentiated, or poorly differentiated.
Differentiation is a term used to describe how clearly the cancer cells can be
distinguished from the surrounding normal tissues and how normal or abnormal
the cells look.
- GX. Grade cannot be
assessed
- G1: Well-differentiated
- G2:
Moderately differentiated
- G3–G4: Poorly differentiated
or undifferentiated
Citations
- American Joint Committee on Cancer (2010). Corpus uteri. In AJCC Cancer Staging Manual, 7th ed., pp. 403–418. New York: Springer.
| By | Healthwise Staff |
|---|
| Primary Medical Reviewer | Sarah Marshall, MD - Family Medicine |
|---|
| Specialist Medical Reviewer | Ross Berkowitz, MD - Obstetrics and Gynecology |
|---|
| Last Revised | November 29, 2010 |
|---|
Last Revised:
November 29, 2010
American Joint Committee on Cancer (2010). Corpus uteri. In AJCC Cancer Staging Manual, 7th ed., pp. 403–418. New York: Springer.